SCHEMBL3628018

SCHEMBL3628018

CC(=O)n1c(-c2ccccc2)c(O)c2ccccc21

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.59
KDM4E B2RXH2 5/20 0.54
KMT2A Q03164 5/20 0.54
RAB9A P51151 4/20 0.54
MAPT P10636 3/20 0.54
ALDH1A1 P00352 2/20 0.54
MEN1 O00255 2/20 0.54
HSD17B10 Q99714 2/20 0.50
CYP2C19 P33261 1/20 0.50
NPC1 O15118 3/20 0.49
AGTR1 P30556 2/20 0.49
TP53 P04637 1/20 0.49
CREBBP Q92793 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
LMNA P02545 2/20 0.49
GLA P06280 1/20 0.49
GAA P10253 1/20 0.49
HPGD P15428 1/20 0.49
TDP1 Q9NUW8 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3551923 0.82 BAZ2B (0.44) POLBKDM4EKMT2ARAB9AMAPT
SCHEMBL3558473 0.82 ACLY (0.47) POLBKDM4EKMT2ARAB9AMAPT
SCHEMBL3560996 0.82 POLB (0.42) POLBKDM4EKMT2ARAB9AMAPT
SCHEMBL3562870 0.82 KMT2A (0.44) POLBKDM4EKMT2ARAB9AMAPT
SCHEMBL170977 0.82 AGTR1 (0.72) KMT2ARAB9AMAPTALDH1A1MEN1
SCHEMBL3563090 0.80 MAPT (0.49) POLBKDM4EKMT2ARAB9AMAPT
SCHEMBL28043494 0.78 POLB (0.53) POLBKDM4EKMT2ARAB9AMAPT
SCHEMBL3557610 0.77 POLB (0.66) POLBKDM4EKMT2ARAB9AMAPT
SCHEMBL15959921 0.77 KDM4E (0.65) POLBKDM4EKMT2ARAB9AMAPT
SCHEMBL6421519 0.76 MAP2 (0.40) POLBKDM4EKMT2ARAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567492-B1 N-ARYLSULFONYL-3-AMINOALKOXYINDOLES SUVEN LIFE SCIENCES LTD (IN) 2013-05-22 EP disclosed
US-7718690-B2 N-arylsulfonyl-3-aminoalkoxyindoles RAMAKRISHNA VENKATA SATYA NIROGI 2010-05-18 US disclosed
US-20090131507-A1 N-arylsulfonyl-3-aminoalkoxyindoles SUVEN LIFE SCIENCES LIMITED (IN) 2009-05-21 US disclosed
EP-1567492-A2 N-ARYLSULFONYL-3-AMINOALKOXYINDOLES Suven Life Sciences Limited (IN) 2005-08-31 EP disclosed
WO-2004048328-A2 N-ARYLSULFONYL-3-AMINOALKOXYINDOLES SUVEN LIFE SCIENCES LIMITED (IN) 2004-06-10 WO disclosed
WO-2004048331-A1 N-ARYLALKYL-3-AMINOALKOXYINDOLES AND THEIR USE AS 5-HT LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2004-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131507-A1 N-arylsulfonyl-3-aminoalkoxyindoles HTR3C, HTR3A, AANAT POLB 3283/4885KDM4E 3751/4885KMT2A 1753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.